ZW19781A1 - Alkaline analgesic capsule - Google Patents

Alkaline analgesic capsule

Info

Publication number
ZW19781A1
ZW19781A1 ZW197/81A ZW19781A ZW19781A1 ZW 19781 A1 ZW19781 A1 ZW 19781A1 ZW 197/81 A ZW197/81 A ZW 197/81A ZW 19781 A ZW19781 A ZW 19781A ZW 19781 A1 ZW19781 A1 ZW 19781A1
Authority
ZW
Zimbabwe
Prior art keywords
alkaline
analgesic capsule
analgesic
capsule
alkaline analgesic
Prior art date
Application number
ZW197/81A
Other languages
English (en)
Inventor
Thomas Michael Tencza
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/179,191 external-priority patent/US4294819A/en
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of ZW19781A1 publication Critical patent/ZW19781A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZW197/81A 1980-08-18 1981-08-14 Alkaline analgesic capsule ZW19781A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/179,191 US4294819A (en) 1980-08-18 1980-08-18 Alkaline analgesic capsule
US06/273,015 US4339428A (en) 1980-08-18 1981-06-18 Capsule product containing high dosage of aspirin in powder or granulated form and alkaline tablet or pellet comprising magnesium carbonate, calcium carbonate and a magnesium dry component

Publications (1)

Publication Number Publication Date
ZW19781A1 true ZW19781A1 (en) 1982-06-16

Family

ID=26875096

Family Applications (1)

Application Number Title Priority Date Filing Date
ZW197/81A ZW19781A1 (en) 1980-08-18 1981-08-14 Alkaline analgesic capsule

Country Status (25)

Country Link
US (1) US4339428A (sv)
AT (1) AT370624B (sv)
AU (1) AU549488B2 (sv)
CA (1) CA1156554A (sv)
CH (1) CH646331A5 (sv)
DD (1) DD201643A5 (sv)
DE (1) DE3132518A1 (sv)
DK (1) DK159374C (sv)
ES (1) ES504797A0 (sv)
FI (1) FI77371C (sv)
FR (1) FR2488508A1 (sv)
GB (1) GB2082456B (sv)
GR (1) GR74618B (sv)
HU (1) HU187354B (sv)
IE (1) IE51501B1 (sv)
IL (1) IL63577A0 (sv)
IT (1) IT1143221B (sv)
LU (1) LU83559A1 (sv)
NL (1) NL8103804A (sv)
NO (1) NO155476C (sv)
NZ (1) NZ198045A (sv)
OA (1) OA06883A (sv)
PT (1) PT73530B (sv)
SE (1) SE451667B (sv)
ZW (1) ZW19781A1 (sv)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4664915A (en) * 1981-07-01 1987-05-12 Bristol-Myers Company Compressed and formed alkaline component suitable for use in buffered aspirin product
US4507276A (en) * 1982-08-20 1985-03-26 Bristol-Myers Company Analgesic capsule
US4578075A (en) * 1982-12-20 1986-03-25 Alza Corporation Delivery system housing a plurality of delivery devices
US4773907A (en) * 1982-12-20 1988-09-27 Alza Corporation Primary delivery system comprising secondary dosage form
US4681583A (en) * 1982-12-20 1987-07-21 Alza Corporation System for dispersing drug in biological environment
US4678661A (en) * 1983-09-28 1987-07-07 Gerhard Gergely Effervescent composition and method of making same
DE3346571A1 (de) * 1983-12-23 1985-07-04 Bayer Ag, 5090 Leverkusen Oral retardierte acetylsalicylsaeureformulierungen
EP0166315B1 (de) * 1984-06-19 1989-08-23 BASF Aktiengesellschaft Magensaftresistent überzogene zylindrische Pankreatin-Mikrotabletten
US4867984A (en) * 1984-11-06 1989-09-19 Nagin K. Patel Drug in bead form and process for preparing same
US4728512A (en) * 1985-05-06 1988-03-01 American Home Products Corporation Formulations providing three distinct releases
IT1209667B (it) * 1985-11-12 1989-08-30 Zambon Spa Composizione effeverscente adattivita' analgesica.
DE3600084A1 (de) * 1986-01-03 1987-07-09 Scherer Gmbh R P Formkoerper sowie verfahren und vorrichtung zur herstellung eines solchen formkoerpers
US4904476A (en) * 1986-03-04 1990-02-27 American Home Products Corporation Formulations providing three distinct releases
US4794001A (en) * 1986-03-04 1988-12-27 American Home Products Corporation Formulations providing three distinct releases
EP0320550A1 (en) * 1987-12-18 1989-06-21 Bristol-Myers Company Non steroidal anti-inflammatory drug composition containing H1 blockers, H2 blockers, beta adrenergic agonists or combinations thereof and an alkalizing agent
US5071842A (en) * 1988-10-14 1991-12-10 Bristol-Myers Squibb Company Aspirin-containing composition including diphenhydramine and an alkalizing agent to reduce gastrointestinal injury potential
US4980175A (en) * 1989-01-03 1990-12-25 Leonard Chavkin Liquid orally administrable compositions based on edible oils
WO1991004018A1 (en) * 1989-09-15 1991-04-04 Cima Labs, Inc. Magnesium carbonate and oil tableting aid
DE4102629A1 (de) * 1991-01-30 1992-08-06 Bayer Ag Pharmazeutischer kaugummi mit acetylsalicylsaeure
HU9202318D0 (en) * 1991-07-22 1992-10-28 Bristol Myers Squibb Co Method for preparing medical preparatives containing didesoxi-purine nucleoside
US5834479A (en) * 1993-03-05 1998-11-10 Mayer; David J. Method and composition for alleviating pain
US5391230A (en) * 1993-07-07 1995-02-21 Eastman Kodak Company Apparatus for holding solid compact medicaments during processing
PL319029A1 (en) * 1994-09-02 1997-07-21 Univ Virginia Commonwealth Pain relieving preparation containing non-nercotic analgesic compound and analgesic action enhancing compound
DE19603402A1 (de) * 1995-02-24 1996-08-29 Basf Ag Weichgelatinekapseln
US6274592B1 (en) * 1997-02-04 2001-08-14 Senju Pharmaceutical Co., Ltd. Method for stabilizing arylcarboxylic acid, stabilizer thereof and aqueous solution containing stabilized arylcarboxylic acid
DE19849848A1 (de) * 1998-10-29 2000-05-04 Lohmann Therapie Syst Lts Oral applizierbare, mit Flüssigkeit spontan zerfallende therapeutische Darreichungsform und Verfahren zu ihrer Herstellung
US6428809B1 (en) * 1999-08-18 2002-08-06 Microdose Technologies, Inc. Metering and packaging of controlled release medication
US6511494B1 (en) 2000-11-17 2003-01-28 Embro Corporation Vein harvesting system and method
US6887492B2 (en) * 2000-12-14 2005-05-03 Leiner Health Services Corp. Magnesium plus interactive agent delivery
US6576665B2 (en) * 2001-04-03 2003-06-10 Braintree Laboratories, Inc. Encapsulated calcium acetate caplet and a method for inhibiting gastrointestinal phosphorous absorption
US20070087048A1 (en) * 2001-05-31 2007-04-19 Abrams Andrew L Oral dosage combination pharmaceutical packaging
EP1455763B1 (en) * 2001-12-21 2007-10-03 Supernus Pharmaceuticals, Inc. Oral capsule formulation with increased physical stability
CA2528164A1 (en) * 2003-06-06 2004-12-16 Takeda Pharmaceutical Company Limited Solid preparation
US7198653B2 (en) 2003-07-31 2007-04-03 Delavau Llc Calcium carbonate granulation
US20050282756A1 (en) * 2004-06-18 2005-12-22 Mehta Nozer M Oral delivery of peptide pharmaceutical compositions
US20060222705A1 (en) * 2005-03-31 2006-10-05 Flanner Henry H Pharmaceutical tablet and apparatus and method for making
US9138414B1 (en) 2006-09-15 2015-09-22 Delavau Llc Calcium supplement having enhanced absorption
US20090087483A1 (en) * 2007-09-27 2009-04-02 Sison Raymundo A Oral dosage combination pharmaceutical packaging
US8439033B2 (en) 2007-10-09 2013-05-14 Microdose Therapeutx, Inc. Inhalation device
DE102008025798C5 (de) 2008-05-29 2015-08-06 Guangdong Fushan Glass Machinery Co., Ltd. Verfahren zum Betreiben eines Rollenofens
WO2011008546A2 (en) * 2009-06-29 2011-01-20 Capricorn Pharma, Inc. Solid and semi-solid dosage forms and systems and methods for forming and packaging thereof
TWI589313B (zh) 2010-01-05 2017-07-01 麥可朵斯斯若波特公司 醫藥遞送封裝及吸入器
US20130143867A1 (en) 2011-12-02 2013-06-06 Sychroneuron Inc. Acamprosate formulations, methods of using the same, and combinations comprising the same
IL230419A0 (en) 2013-05-23 2014-04-30 Naveh Pharma 1996 Ltd Products containing magnesium and their uses
CN105431144A (zh) 2013-06-05 2016-03-23 思康脑侒股份有限公司 阿坎酸制剂、使用阿坎酸制剂的方法以及包含阿坎酸制剂的组合
US11160759B1 (en) 2015-10-09 2021-11-02 Combocap, Inc. Capsule with internal diaphragm for improved bioavailability

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA593581A (en) * 1960-03-01 W. E. Harrisson Joseph Analgesic product
FR808949A (fr) * 1936-07-31 1937-02-18 Perfectionnements à la préparation des cachets pharmaceutiques
US2224256A (en) * 1938-08-05 1940-12-10 Baker Chem Co J T Pharmaceutical preparation
GB613080A (en) * 1946-05-17 1948-11-22 Myer Coplans Improvements in the preparation of stable medicinal salts of acetylsalicylic acid
US2698332A (en) * 1951-04-20 1954-12-28 Reheis Company Inc Aspirin derivative and method of making
GB754364A (en) * 1953-10-09 1956-08-08 Drug Houses Of Australia Ltd Improvements in medicinal preparations containing acetylsalicylic acid
US2918485A (en) * 1955-09-21 1959-12-22 Keystone Chemurgic Corp Dihydroxy aluminum salicylates
US2889248A (en) * 1955-12-13 1959-06-02 Drug Processors Inc Therapeutic composition containing aluminum proteinate
US2801951A (en) * 1956-01-09 1957-08-06 Sterling Drug Inc Stabilized analgesic compositions
GB827529A (en) * 1956-02-27 1960-02-03 Macleans Ltd Improvements in or relating to the manufacture of tablets
US2888382A (en) * 1957-10-28 1959-05-26 Upjohn Co Therapeutic composition and process
BE585778A (sv) * 1958-04-18
US3019169A (en) * 1958-06-23 1962-01-30 Sterling Drug Inc Salicylate dry shell coating of dry 4-aminoquinoline core, and dry-compressing tablet-making process
US3323992A (en) * 1960-09-29 1967-06-06 Keystone Chemurgic Corp Antacid composition of hydrated magnesium aluminate containing bound sulfate
US3341416A (en) * 1963-12-11 1967-09-12 Ncr Co Encapsulation of aspirin in ethylcellulose and its product
GB1204580A (en) 1968-10-05 1970-09-09 Aspro Nicholas Ltd Pharmaceutical dosage forms
US3608064A (en) * 1969-10-07 1971-09-21 Anthony H Lamb Milk-buffered aspirin
US4167558A (en) * 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
GB1576376A (en) * 1977-03-30 1980-10-08 Benzon As Alfred Multiple-unit drug dose
US4294819A (en) * 1980-08-18 1981-10-13 Bristol-Myers Company Alkaline analgesic capsule

Also Published As

Publication number Publication date
NO155476C (no) 1987-04-08
OA06883A (fr) 1983-04-30
IT8149078A0 (it) 1981-08-10
PT73530A (en) 1981-09-01
GR74618B (sv) 1984-06-29
IL63577A0 (en) 1981-11-30
NO155476B (no) 1986-12-29
AT370624B (de) 1983-04-25
GB2082456A (en) 1982-03-10
NL8103804A (nl) 1982-03-16
DE3132518A1 (de) 1982-05-27
FR2488508B1 (sv) 1985-05-10
FI812505L (fi) 1982-02-19
SE451667B (sv) 1987-10-26
DK159374B (da) 1990-10-08
SE8104881L (sv) 1982-02-19
DK159374C (da) 1991-07-01
AU7368281A (en) 1982-02-25
IE811881L (en) 1982-02-18
CH646331A5 (de) 1984-11-30
HU187354B (en) 1985-12-28
DD201643A5 (de) 1983-08-03
ES8301622A1 (es) 1982-12-16
PT73530B (en) 1983-10-20
LU83559A1 (fr) 1982-04-14
US4339428A (en) 1982-07-13
CA1156554A (en) 1983-11-08
NZ198045A (en) 1985-01-31
DK362781A (da) 1982-02-19
FI77371B (fi) 1988-11-30
GB2082456B (en) 1984-10-24
ATA355281A (de) 1982-09-15
IE51501B1 (en) 1987-01-07
AU549488B2 (en) 1986-01-30
ES504797A0 (es) 1982-12-16
NO812678L (no) 1982-02-19
FI77371C (sv) 1989-03-10
FR2488508A1 (fr) 1982-02-19
IT1143221B (it) 1986-10-22

Similar Documents

Publication Publication Date Title
ZW19781A1 (en) Alkaline analgesic capsule
ZA815435B (en) Alkaline analgesic capsule
ZA835033B (en) Analgesic capsule
PL238844A1 (en) Capsule
IL63880A0 (en) Medicament containing 2-amino-6-trifluoromethoxy-benzothiazole
GB2069466B (en) Break away device
JPS56139420A (en) Drug
GB8329562D0 (en) Analgesic agent
GB2067900B (en) Medicinal tablets
ZA813832B (en) Grouting capsule
JPS5732230A (en) Instetine-soluble capsule
MTP884B (en) Pharmaceutical preparationes
DE3171905D1 (en) Medicament capsules for rectal application
DE3166258D1 (en) Cover capsule
JPS56115471A (en) Shelter capsule
GB2318631B (en) Warheads
JPS56139328A (en) Capsule structure
GB8416176D0 (en) Forming capsules
GB2079330B (en) Knotters
GB2079329B (en) Knotters
JPS579079A (en) Connector for capsule
PH18681A (en) Methoxsalem dosage forms
JPS5772647A (en) Hard capsule for drug
GB2124261B (en) Knotters
GB2081312B (en) Knotters